Relaxin-3 and its role in neuroendocrine function
Barbara M C McGowan1, Sarah A Stanley, Mohammad A Ghatei
1Department of Investigative Medicine, Division of Investigative Science, Imperial College London, Hammersmith Hospital, London, UK.
Relaxin-3, a brain peptide, may coordinate appetite, thyroid, and reproductive functions. Further research is needed to confirm its physiological roles and the receptors involved in these hypothalamic actions.
Area of Science:
- Neuroendocrinology
- Metabolic Regulation
- Reproductive Physiology
Background:
- The hypothalamus regulates energy homeostasis and endocrine functions.
- Relaxin-3 is a neuropeptide expressed in the brainstem with projections to the hypothalamus.
- Relaxin-3 is thought to act via RXFP3 and potentially RXFP1 receptors in the hypothalamus.
Purpose of the Study:
- To review evidence for relaxin-3's role as a hypothalamic orexigenic peptide.
- To discuss potential roles in the hypothalamo-pituitary-thyroid (HPT) and hypothalamo-pituitary-gonadal (HPG) axes.
- To compare central endocrine effects of relaxin-3 with relaxin.
Main Methods:
- Review of existing literature on relaxin-3's effects on energy expenditure and HPT axis.
- Discussion of studies investigating relaxin-3's role in the HPG axis.
- Comparative analysis of central endocrine actions of relaxin-3 and relaxin.
Main Results:
- Evidence suggests relaxin-3 may act as a hypothalamic orexigenic (appetite-stimulating) peptide.
- Relaxin-3 influences the HPT axis and energy expenditure.
- Preliminary studies suggest a role for relaxin-3 in the HPG axis, impacting reproductive function.
Conclusions:
- Relaxin-3 may function as a hypothalamic signal integrating appetite, thyroid function, and reproductive status.
- Further investigation is required to establish the physiological significance of these roles.
- Identifying the specific receptors mediating relaxin-3's central actions is crucial.
More Related Videos
08:39Ex Vivo Release of Calcitonin Gene-Related Peptide from the Trigeminovascular System in Rodents
Published on: May 16, 2022
08:15Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
Related Concept Videos
Neurotransmitters
Neurotransmitters
Parasympathetic Signaling
The effects of...
Peripherally and Centrally Acting Muscle Relaxants: A Comparison
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic drugs,...
Centrally Acting Muscle Relaxants: Therapeutic Uses
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...
Relaxation of Skeletal Muscles
When an action potential reaches the axon terminal, it depolarizes the membrane and opens voltage-gated sodium channels. Sodium ions enter the cell, further depolarizing the presynaptic membrane. This depolarization causes voltage-gated calcium channels to open.
